Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
2d
Interesting Engineering on MSNFDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentThe FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
A Samsung blog has claimed that Galaxy S25 Ultra owners can get a Bluetooth-enabled S Pen as a standalone purchase. This comes after Samsung ditched Bluetooth from the S25 Ultra’s included S Pen.
However, one thing is substantially different with this year’s Ultra phone: the S Pen. Unlike all previous S Pens found in every other Galaxy S Ultra phone, the Samsung Galaxy S25 Ultra S Pen ...
The Samsung Galaxy S25 Ultra S Pen no longer supports Bluetooth connectivity, removing features like Air Actions. Samsung says the change was made due to low user engagement and suggests using ...
Samsung has since clarified that Bluetooth support for the S Pen is, in fact, gone. According to Samsung, the blog post was made in error, and the Galaxy S25 Ultra will not offer any Bluetooth ...
But fear not, S Pen fans: a new announcement suggests that Samsung could release a Bluetooth-enabled S Pen for the S25 Ultra after all – but it’ll cost you extra. A footnote affixed to a ...
ST. PAUL, Minn. — Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers following its 2018 lawsuit over unaffordable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results